HomeInsightsDividend

Vaidya Sane Ayurved Laboratories Ltd dividend

Vaidya Sane Ayurved Laboratories Ltd dividend

download
stocks purchased

₹ 0.1 Cr

Volume transacted

stocks purchased

8.8 K

stocks traded

Last Updated time: 21 Jul 15:12 PM

Image

Vaidya Sane Ayurved Laboratories Ltd

NSE: MADHAVBAUG

DPS

0.25

Last updated : FY 2023

Key Highlights

    The Dividend per Share of Vaidya Sane Ayurved Laboratories Ltd is ₹ 0.25 as of 2023 .a1#The Dividend Payout of Vaidya Sane Ayurved Laboratories Ltd changed from 5.06 % on March 2019 to 5.06 % on March 2023 . This represents a CAGR of 0.00% over 1 years. a1#The Latest Trading Price of Vaidya Sane Ayurved Laboratories Ltd is ₹ 147.1 as of 19 Jul 15:30 .a1#The Market Cap of Vaidya Sane Ayurved Laboratories Ltd is ₹ 247.07 crore as of March 2023 .a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Share Price Vs Dividend Yield

swot
swot
×

Historical Dividend Payout of Vaidya Sane Ayurved Laboratories Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Vaidya Sane Ayurved Laboratories Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '235

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Vaidya Sane Ayurved Laboratories Ltd

NSE: MADHAVBAUG

PRICE

147.1

-2.95 (-1.97%)

stock direction

Last updated : 19 Jul 15:30

SWOT Analysis Of Vaidya Sane Ayurved Laboratories Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


Image

Vaidya Sane Ayurved Laboratories Ltd

NSE: MADHAVBAUG

MARKETCAP

247 crore

Last updated : March 2023

About Vaidya Sane Ayurved Laboratories Ltd

About Vaidya Sane Ayurved Laboratories Ltd

    The Company was originally incorporated as a Private Limited Company under the Companies Act, 1956 pursuant to a Certificate of Incorporation issued by the Registrar of Companies, Pune dated April 6, 1999 with the name Vaidya Sane Ayurved Laboratories Private Limited'. Subsequently, Company was converted into to a Public Limited Company and the name of Company was changed to Vaidya Sane Ayurved Laboratories Limited' by a Special Resolution passed on November 19, 2021. A fresh Certificate of Incorporation consequent upon conversion was issued on November 25, 2021 by the Registrar of Companies, Pune. Dr. Rohit Madhav Sane is the Present Promoter of the Company. The Company is a unique medical service institution that strives to treat chronic ailments like cardiac disease, diabetes, hypertension and obesity with the distinctive outlook of amalgamating technology with traditional healing of Ayurveda. Its approach to treatment using non-invasive, multidisciplinary and innovative therapies which has helped establish the Company as a dependable option for treating the chronic ailments. The Company is primarily engaged in research and development in ayurvedic medicines and the sale of ayurvedic medicines & products through its various franchises and own clinics. The Company is also engaged in providing Ayurvedic medical professional services across its various clinics including panchkarma and other ayurvedic treatments through running of ayurvedic Hospital. The Company is a health care provider primarily in the India's chronic care ecosystem. The Company provide healthcare services through Madhavbaug clinics. It operate 274 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa and Karnataka. Out of these 52 are company owned and 222 are franchise clinics. The Company also operate two cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur respectively. Currently, the Company has a network including 274 Clinics and 2 Fully equipped Hospital. The Company has entered into MOU dated April 1, 2019 with Vaidya Sane's Ayurvedic Education And Agricultural Research Trust for the entire management, medical services and treatments being carried out at Khopoli Hospital. The Company use clinic based health care delivery model along with tele-medicine to ensure easy accessibility to patients. Apart from treatments, as a means of raising awareness about disease and its associated complications, the Company conduct a number of workshops, support events etc. with a singular objective of helping patients manage their chronic non-communicable conditions more effectively as well. At Madhavbaug clinics and hospitals, the Company use modern diagnostics, diet and physiotherapy and advanced Ayurveda to provide Heart disease, Diabetes, Hypertension & Obesity reversal treatments to our patients. This helps in improving the exercise tolerance of patients - improvement in grade of symptoms, improvement in maximum oxygen uptake, reduction in Hba1c, and metabolic equivalents (METs). In 2006, First Cardiac Prevention and Rehabilitation Hospital was set up at Khopoli and inaugurated opening of first Madhavbaug Clinic at Dombivili, Maharashtra. In 2009, the Company established in house research and development team at Thane. In 2012, the Company established the First Cardiac Prevention and Rehabilitation Hospital at Nagpur. In 2013, the Company inaugurated opening of 100th Madhavbaug Clinic at Kankavli, in Ratnagiri. In 2014, the Company launched Arogyam Hriday Sampada with a Mission to create awareness of heart disease. In 2015, the Company launched therapies for risk factors such as diabetes, obesity and hypertension at Madhavbaug Clinics. In 2016, the Company launched a research based disease wise diet kits at Madhavbaug Clinics for aiding healthcare programmes and established Madhavbaug Institute of Preventive Cardiology with MUHS. These kits aid in the recovery and rehabilitation of its patients. In 2017, Madhavbaug Clinics received Frost and Sullivan's 2017 India Best Practices Award and the Company's randomized controlled trial by Madhavbaug was published in Indian Heart Journal, Official publication of Cardiological Society of India. In 2018, Madhavbaug Clinics ventured into India Book of Records for conducting GTT of 661 diabetic patients in single day at 13 different locations. The Company participated as main sponsor of World Ayurved Congress 2018 held in Ahmedabad. Apart from this, the Company inaugurated the opening of 200th Madhavbaug Clinic at Nanded, in Maharashtra. In 2019, Madhavbaug introduced research based heart blockage management program. The Company achieved new registrations of over 90,000 patients and more than 27,000 stress tests were conducted and over 3,00,000 panchakarma procedures performed. In 2020, the Company launched MIB Pulse Mobile Application for patient engagement. In 2021, the Company inaugurated the opening of 250th Madhavbaug Clinic at Vashi. The Company's conducted Research trial on one year follow-up of diabetes patients treated by Madhavbaug was published in Journal of Association of Physicians of India. The Company achieved MIB Pulse Mobile Application over 1,00,000 downloads, which was developed by a third-party vendor. It calculated the risk of getting a heart attack by considering risk factors that a person has and also gave tips on how to reduce & manage the risk. The Company has also launched online portal 'www.madhavbaugwellness.com' for new wellness products such as Madhav Shakti Atta, apple cider vinegar, prosix dosa mix, nutriboom ghavan mix, digy smooth moong daliya, lentigrain idli mix, Insta health thalli peeth, power mix muthiya aata, diaphragm kadha, arj kadha, groundnut oil, amla lichi syrup, etc. and many more.

Vaidya Sane Ayurved Laboratories Ltd News Hub

News

Vaidya Sane Ayurved Laboratories announces board meeting date

Vaidya Sane Ayurved Laboratories will hold a meeting of the Board of Directors of the Comp...

Read more

23 May 202415:23

News

Vaidya Sane Ayurved Laboratories to hold board meeting

Vaidya Sane Ayurved Laboratories will hold a meeting of the Board of Directors of the Comp...

Read more

08 Nov 202319:55

News

Vaidya Sane Ayurved Laboratories schedules AGM

Vaidya Sane Ayurved Laboratories announced that the 24th Annual General Meeting (AGM) of t...

Read more

17 Aug 202313:41

News

Vaidya Sane Ayurved Laboratories schedules board meeting

Vaidya Sane Ayurved Laboratories will hold a meeting of the Board of Directors of the Comp...

Read more

11 Aug 202310:38

News

Vaidya Sane Ayurved Laboratories EGM scheduled

Vaidya Sane Ayurved Laboratories announced that an Extra Ordinary General Meeting (EGM) of...

Read more

12 Jul 202314:01

News

Vaidya Sane Ayurved Laboratories to convene board meeting

Vaidya Sane Ayurved Laboratories will hold a meeting of the Board of Directors of the Comp...

Read more

08 Jul 202309:55

up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199